New strategy exploits a hidden genetic vulnerability in multiple cancers
Researchers have found a surprisingly common vulnerability in a broad variety of cancers and have begun designing drug compounds to exploit it, in a study led by investigators at Weill Cornell Medicine.
Read original article on The Medical News →Related news
-
Engineers address key hurdle for exhaled breath diagnostics
United Kingdom
-
Are there better ways to protect athletes from blows to the head? Researchers test student football players
United Kingdom
-
New study evaluates quantum machine learning for lung cancer prediction
United Kingdom
-
New age-specific prediction models improve incomplete Kawasaki disease diagnosis
United Kingdom
-
Mount Sinai receives NIH grant to study advanced MRI methods for locating seizures
United Kingdom
-
New computational tool simulates evolution of jumping genes
United Kingdom
-
'Heart-in-a-dish' paves way for personalized treatment for heart failure
United Kingdom
-
Ensuring health equity with the use of AI
United Kingdom